Olfactory Neuroblastoma

Symptoms, Doctors, Treatments, Advances & More

Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as an Elite provider by MediFind in the treatment of Olfactory Neuroblastoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Awake Craniotomy, and Craniectomy. Dr. Gallia is board certified in American Board Of Neurological Surgery.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Elite provider by MediFind in the treatment of Olfactory Neuroblastoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy. Dr. London is board certified in Head And Neck Surgery.

Eric W. Wang, MD, is professor of Otolaryngology, Neurological Surgery, and Ophthalmology at the University of Pittsburgh School of Medicine, Director of the Division of Rhinology, and Co-Director of the UPMC Center for Cranial Base Surgery. Dr. Wang is also Executive Vice Chair of the Department of Otolaryngology. Dr. Wang completed his undergraduate studies in biochemistry at Rice University and his medical degree at Baylor College of Medicine in Houston. He completed his internship and residency at Barnes-Jewish Hospital and Washington University School of Medicine in Saint Louis. Dr. Wang is rated as an Elite provider by MediFind in the treatment of Olfactory Neuroblastoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Cerebrospinal Fluid Leak, Pituitary Tumor, Endoscopy, and Turbinectomy. Dr. Wang is board certified in American Board Of Otolaryngology - Head And Neck Surgery. Dr. Wang is currently accepting new patients.